The US Federal Trade Commission has reportedly filed an amicus brief urging an appeals court to reverse an earlier dismissal of a pharmaceutical pay-for-delay lawsuit.
The FTC filed the brief in the US Court of Appeals for the Third Circuit, asking it to reverse the dismissal of Lamictal Direct Purchaser Antitrust …read more
Source: Global Competition Law Blogs